Literature DB >> 3954958

Collagen and elastin changes in D-penicillamine-induced pseudoxanthoma elasticum-like skin.

N Light, R H Meyrick Thomas, A Stephens, J D Kirby, P R Fryer, N C Avery.   

Abstract

A patient with cystinuria who was treated with large doses of D-penicillamine for 19 years developed skin abnormalities resembling those seen in pseudoxanthoma elasticum. Biochemical and histological examination of the dermis showed that the collagen content, the ratio of the major genetic forms of collagen and the distribution of collagen types was normal. Light microscopy demonstrated the presence of vastly increased amounts of elastin in the dermis, and the individual elastin fibres were shown by electron microscopy to be abnormal; chemical analysis showed the elastin to be poorly cross-linked. Some of the collagen also appeared structurally abnormal, and biochemically resembled that seen in the dermis of a young child with respect to cross-linking and hexosyl-lysine content. The therapy led to an increased deposition of collagen and elastin fibres which appeared abnormal, and resulted in an increase in total skin surface area. These data indicate that D-penicillamine was not fully effective in inhibiting collagen and elastin cross-linking, and appeared to prevent or inhibit the natural maturation process of the collagen.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3954958     DOI: 10.1111/j.1365-2133.1986.tb02832.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

1.  Penicillamine-induced elastosis perforans serpiginosa and pseudo-pseudoxanthoma elasticum.

Authors:  Lauren E Heusinkveld; Daniel Michalik; Jennifer Lucas
Journal:  Int J Womens Dermatol       Date:  2021-04-05

2.  D-penicillamine Induced Degenerative Dermopathy.

Authors:  Sujay Khandpur; Naresh Jain; Shweta Singla; Priti Chatterjee; Madhuri Behari
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.